{
  "id": "oaia2",
  "display_name": "Oral Anti-Inflammatory Asthma Drugs (Leukotriene Receptor Antagonists And Inhibitors Of Lipo-Oxygenase) (SHHS2)",
  "description": "Participant taking ORAL ANTI-INFLAMMATORY ASTHMA DRUGS (LEUKOTRIENE RECEPTOR ANTAGONISTS AND INHIBITORS OF LIPO-OXYGENASE) within two weeks of the SHHS2 visit.  All medications were recorded during the interview, and medication information was later categorized by physician review.",
  "type": "choices",
  "domain": "noyes01",
  "labels": [
    "OAIA2",
    "asthma",
    "respiratory",
    "inflammation"
  ],
  "commonly_used": true,
  "forms": [
  "shhs2_medication_form"
  ]
}
